CAPIZZI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 256
EU - Europa 103
AS - Asia 50
SA - Sud America 3
AF - Africa 2
Totale 414
Nazione #
US - Stati Uniti d'America 255
IT - Italia 25
DE - Germania 23
FR - Francia 15
CN - Cina 10
IN - India 10
JP - Giappone 10
GB - Regno Unito 7
IE - Irlanda 7
BG - Bulgaria 6
TW - Taiwan 5
CZ - Repubblica Ceca 4
SG - Singapore 4
BR - Brasile 3
HK - Hong Kong 3
HU - Ungheria 3
KR - Corea 3
SI - Slovenia 3
ES - Italia 2
NL - Olanda 2
TR - Turchia 2
BZ - Belize 1
EG - Egitto 1
FI - Finlandia 1
GR - Grecia 1
IQ - Iraq 1
IR - Iran 1
PH - Filippine 1
PT - Portogallo 1
RU - Federazione Russa 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 414
Città #
Santa Cruz 24
Ashburn 20
Fairfield 12
Buffalo 11
Seattle 10
Bremen 8
Chicago 7
Dublin 7
Tappahannock 7
Boardman 6
Dallas 6
Houston 6
Schaumburg 6
Sofia 6
Wilmington 6
Ann Arbor 5
Cambridge 5
Taipei 5
Woodbridge 5
Beijing 4
Milan 4
Mountain View 4
Phoenix 4
Southend 4
Syracuse 4
Tokyo 4
Bengaluru 3
Brookline 3
Chapel Hill 3
Debrecen 3
Langenhagen 3
Los Angeles 3
New York 3
Newton 3
Paris 3
San Diego 3
Bhubaneswar 2
Campina Grande 2
Cisano Bergamasco 2
Cosenza 2
Delhi 2
Guangzhou 2
Gurgaon 2
Henderson 2
Istanbul 2
Jersey City 2
Las Vegas 2
Litija 2
Marseille 2
Naples 2
Parma 2
Riva 2
San Prisco 2
Amsterdam 1
Ancona 1
Andria 1
Badajoz 1
Bangalore 1
Berlin 1
Bloomsbury 1
Boulder 1
Bratislava 1
Central 1
Central District 1
Clearwater 1
Clifton Park 1
Costabissara 1
Council Bluffs 1
Crugers 1
Cuneo 1
Florence 1
Frankfurt am Main 1
Groningen 1
Gwanak-gu 1
Halmstad 1
Hamburg 1
Hangzhou 1
Helsinki 1
Hiji 1
Hillsboro 1
Hradec Králové 1
Kirkland 1
Lake Forest 1
Ljubljana 1
Makishi 1
Miami 1
Milpitas 1
Muizenberg 1
Munich 1
Murcia 1
Nanjing 1
Nice 1
Nishi-Tokyo-shi 1
Pescara 1
Piemonte 1
Quezon City 1
Redmond 1
Saint Petersburg 1
San Francisco 1
Scottsdale 1
Totale 301
Nome #
Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer, file e1dcb338-7cc2-7715-e053-1705fe0a6cc9 129
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report, file e1dcb335-0258-7715-e053-1705fe0a6cc9 110
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study, file e1dcb337-8831-7715-e053-1705fe0a6cc9 64
Similarities and differences between clear cell tubulo-papillary and conventional clear cell renal cell carcinoma: A comparative phenotypical and mutational analysis, file e1dcb335-91b9-7715-e053-1705fe0a6cc9 56
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients, file e1dcb32d-da0f-7715-e053-1705fe0a6cc9 24
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance., file e1dcb32c-3ae1-7715-e053-1705fe0a6cc9 14
Nodal Occult Metastases in Intermediate- and High-Risk Prostate Cancer Patients Detected Using Serial Section, Immunohistochemistry, and Real-Time Reverse Transcriptase Polymerase Chain Reaction: Prospective Evaluation With Matched-Pair Analysis., file e1dcb32d-e652-7715-e053-1705fe0a6cc9 14
Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer, file e1dcb32d-da0a-7715-e053-1705fe0a6cc9 10
Molecular alterations in proteasomes of rat liver during aging result in altered proteolytic activities., file e1dcb32c-5e69-7715-e053-1705fe0a6cc9 4
BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype, file e1dcb32f-8c93-7715-e053-1705fe0a6cc9 3
Totale 428
Categoria #
all - tutte 1.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.251


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 3 1 3
2020/202141 1 3 1 2 0 2 2 4 7 1 15 3
2021/2022125 3 2 5 8 16 10 4 8 8 9 37 15
2022/2023182 20 18 30 28 15 12 14 8 9 7 16 5
2023/202473 8 8 4 2 12 13 11 7 2 6 0 0
Totale 428